Development of SARS-CoV-2 Antigen Test (CoV2Ag) for the ADVIA Centaur and Atellica IM systems

Award Notice Posted

Solicitation number
75A50121P00005
Agency
Awarded
to Siemens Healthcare Diagnostics Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
75A50121P00005 Federal contract award
Place of performance
Norwood MA 02062 USA

Notice details come from SAM.gov. Updated .

About this opportunity

This Award Notice from the Department of Health and Human Services provides $13 million to Siemens Healthcare Diagnostics Inc. to develop SARS-CoV-2 antigen tests for the ADVIA Centaur and Atellica IM diagnostic systems. The class justification attached allows for contracting without full and open competition due to the urgent need to respond to the COVID-19 pandemic, and covers supplies, services, and research with a period of performance through September 2021 for an estimated total value over $100 million.

Notice text

This justification for unusual and compelling urgency is due to the public health emergency caused by COVID-19, which was declared a global pandemic by the WHO. The first confirmed case of COVID-19 in the United States was announced on January 21, 2020 and a national emergency was declared via Presidential Proclamation on March 13, 2020. The ultimate spread, length of time, and severity of the COVID-19 outbreak is unknown as this time and current data indicate that COVID-19 has begun to spread
exponentially, in the typical pattern for an epidemic.. The goal of the ongoing U.S. public health response is to respond to and mitigate sustained spread of COVID-19 in this country.
 

Awarded contract 75A50121P00005 to SIEMENS HEALTHCARE DIAGNOSTICS INC. for 13000000.00 on 2020-11-02.

Files

File Type Posted
Class J and A Final 3.21.20.pdf PDF
Class J and A Final 3.21.20 (Redacted).pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors